Search research articles
Contact Us
Filters
Showing results (531-540 of 654) with videos related to
Page
of 66
Sort By:
Plos Neglected Tropical Diseases
|
July 10, 2023
A Phase-I pharmacokinetic, safety and food-effect study on flubentylosin, a novel analog of Tylosin-A having potent anti-Wolbachia and antifilarial activity
Negar Alami, David C Carter, Nisha V Kwatra, et al.
Journal of Medicinal Chemistry
|
April 8, 2009
Water-soluble prodrugs of the human immunodeficiency virus protease inhibitors lopinavir and ritonavir
David A DeGoey, David J Grampovnik, William J Flosi, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
December 22, 2010
Pharmacokinetic modeling and [¹²³]5-IA-85380 single photon emission computed tomography imaging in baboons: optimization of dosing regimen for ABT-089
Chih-Liang Chin, Robert A Carr, Daniel A Llano, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
May 28, 2010
In vivo pharmacological characterization of a novel selective alpha7 neuronal nicotinic acetylcholine receptor agonist ABT-107: preclinical considerations in Alzheimer's disease
R Scott Bitner, William H Bunnelle, Michael W Decker, et al.
Antiviral Chemistry & Chemotherapy
|
July 14, 2007
Pharmacokinetic enhancement of the hepatitis C virus protease inhibitors VX-950 and SCH 503034 by co-dosing with ritonavir
Dale J Kempf, Cheri Klein, Hui-Ju Chen, et al.
Journal of Cardiovascular Pharmacology
|
July 27, 2005
Pharmacological characterization of the novel dihydropyridine potassium channel opener, (9R)-9-(3-iodo-4-methylphenyl)-5,9-dihydro-3H-furo[3,4-b]pyrano[4,3-e]pyridine-1,8(4H,7H)-dione (A-325100), and the regulation of cardiovascular function in conscious and anesthetized beagle dogs
Ryan M Fryer, Pamela A Rakestraw, Lee C Preusser, et al.
Pain
|
June 20, 2006
(L)-Phenylglycine, but not necessarily other alpha2delta subunit voltage-gated calcium channel ligands, attenuates neuropathic pain in rats
James J Lynch, Prisca Honore, David J Anderson, et al.
Life Sciences
|
November 24, 1998
The effects of diminishing albumin binding to some Endothelin receptor antagonists
B G Szczepankiewicz, R B Bal, T W von Geldern, et al.
Frontiers in Genetics
|
November 1, 2012
AhR activation underlies the CYP1A autoinduction by A-998679 in rats
Michael J Liguori, Chih-Hung Lee, Hong Liu, et al.
Msphere
|
November 19, 2025
From description to implementation: key takeaways from the 3rd African Microbiome Symposium
Charissa C Marsh, Kristien Nel Van Zyl, Olubukola Oluranti Babalola, et al.
Page
of 66
Search research articles
Search
Showing results (531-540 of 654) with videos related to
Sort By:
Page
of 66
Plos Neglected Tropical Diseases
|
July 10, 2023
A Phase-I pharmacokinetic, safety and food-effect study on flubentylosin, a novel analog of Tylosin-A having potent anti-Wolbachia and antifilarial activity
Negar Alami, David C Carter, Nisha V Kwatra, et al.
Journal of Medicinal Chemistry
|
April 8, 2009
Water-soluble prodrugs of the human immunodeficiency virus protease inhibitors lopinavir and ritonavir
David A DeGoey, David J Grampovnik, William J Flosi, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
December 22, 2010
Pharmacokinetic modeling and [¹²³]5-IA-85380 single photon emission computed tomography imaging in baboons: optimization of dosing regimen for ABT-089
Chih-Liang Chin, Robert A Carr, Daniel A Llano, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
May 28, 2010
In vivo pharmacological characterization of a novel selective alpha7 neuronal nicotinic acetylcholine receptor agonist ABT-107: preclinical considerations in Alzheimer's disease
R Scott Bitner, William H Bunnelle, Michael W Decker, et al.
Antiviral Chemistry & Chemotherapy
|
July 14, 2007
Pharmacokinetic enhancement of the hepatitis C virus protease inhibitors VX-950 and SCH 503034 by co-dosing with ritonavir
Dale J Kempf, Cheri Klein, Hui-Ju Chen, et al.
Journal of Cardiovascular Pharmacology
|
July 27, 2005
Pharmacological characterization of the novel dihydropyridine potassium channel opener, (9R)-9-(3-iodo-4-methylphenyl)-5,9-dihydro-3H-furo[3,4-b]pyrano[4,3-e]pyridine-1,8(4H,7H)-dione (A-325100), and the regulation of cardiovascular function in conscious and anesthetized beagle dogs
Ryan M Fryer, Pamela A Rakestraw, Lee C Preusser, et al.
Pain
|
June 20, 2006
(L)-Phenylglycine, but not necessarily other alpha2delta subunit voltage-gated calcium channel ligands, attenuates neuropathic pain in rats
James J Lynch, Prisca Honore, David J Anderson, et al.
Life Sciences
|
November 24, 1998
The effects of diminishing albumin binding to some Endothelin receptor antagonists
B G Szczepankiewicz, R B Bal, T W von Geldern, et al.
Frontiers in Genetics
|
November 1, 2012
AhR activation underlies the CYP1A autoinduction by A-998679 in rats
Michael J Liguori, Chih-Hung Lee, Hong Liu, et al.
Msphere
|
November 19, 2025
From description to implementation: key takeaways from the 3rd African Microbiome Symposium
Charissa C Marsh, Kristien Nel Van Zyl, Olubukola Oluranti Babalola, et al.
Page
of 66